CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER

The sequential use of several lines of endocrine therapy is considered the standard for the treatment of metastatic breast cancer, expressing estrogen or progesterone receptors. PALOMA-1, -2 and -3 studies showed that the combination of the inhibitor of CDK4/6, palbociclib, with endocrine therapy si...

Full description

Bibliographic Details
Main Authors: E. N. Imyanitov, T. Yu. Semiglazova
Format: Article
Language:Russian
Published: ABV-press 2017-12-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
metastatic er-positive breast cancer
factors of poor prognosis
resistance
hormonal therapy
palbociclib
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/561

Internet

https://ojrs.abvpress.ru/ojrs/article/view/561

Similar Items